Msthods phylum Cnidaria classes Hydrozoa, Detoxificationn, Snake venom detoxification methods Cubozoa comprises approximately 10, jellyfish species distributed throughout the world Snake venom detoxification methods, Drug development programs may be discontinued due to several factors, like intellectual property disputes, changes in the program leadership, lack of funding, among other business decisions. obliqua prothrombim activator protease and Losac L. Pathophysiological and Pharmacological Effects of Snake Venom Components: Molecular Targets.

Snake venom detoxification methods -

In: Lanza R, Atala A, editors. Essentials of Stem Cell Biology , 3rd ed. Boston: Academic Press Albanesi C, Madonna S, Gisondi P, Girolomoni G. The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis. Front Immunol —. Pivarcsi A, Kemeny L, Dobozy A. Innate Immune Functions of the Keratinocytes.

A Rev Acta Microbiol Immunol Hungarica 51 3 — Lebre MC, van der Aar AMG, van Baarsen L, van Capel TMM, Schuitemaker JHN, Kapsenberg ML, et al. Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9.

J Invest Dermatol 2 — Costal-Oliveira F, Stransky S, Guerra-Duarte C, Naves de Souza DL, Vivas-Ruiz DE, Yarlequé A, et al. L-Amino Acid Oxidase From Bothrops Atrox Snake Venom Triggers Autophagy, Apoptosis and Necrosis in Normal Human Keratinocytes.

Sci Rep 9 1 —. Stransky S, Costal-Oliveira F, Lopes-de-Souza L, Guerra-Duarte C, Chávez-Olórtegui C, Braga VMM. In Vitro Assessment of Cytotoxic Activities of Lachesis Muta Muta Snake Venom. PloS neglected Trop Dis 12 4 :e Silva-de-Franca F, Villas-Boas IM, Serrano SMT, Cogliati B, Chudzinski SAA, Lopes PH, et al.

Naja Annulifera Snake: New Insights Into the Venom Components and Pathogenesis of Envenomation. PloS Negl Trop Dis 13 1 :e Bhattacharjee P, Mitra J, Bhattacharyya D. L-Amino Acid Oxidase From Venoms.

Dordrecht: Springer Netherlands Paixão-Cavalcante D, van den Berg CW, de Freitas Fernandes-Pedrosa M, Gonçalves de Andrade RM, Tambourgi DV. Role of Matrix Metalloproteinases in HaCaT Keratinocytes Apoptosis Induced by Loxosceles Venom Sphingomyelinase D.

J Invest Dermatol 1 —8. Telser A. Molecular Biology of the Cell. New York: Garland Science Al-Soudi A, Kaaij MH, Tas SW. Endothelial Cells: From Innocent Bystanders to Active Participants in Immune Responses.

Autoimmun Rev 16 9 — Khakpour S, Wilhelmsen K, Hellman J. Vascular Endothelial Cell Toll-like Receptor Pathways in Sepsis. Innate Immun 21 8 — Pugin J, Ulevitch RJ, Tobias PS.

Tumor Necrosis Factor-Alpha and Interleukin-1 Beta Mediate Human Endothelial Cell Activation in Blood At Low Endotoxin Concentrations. J Inflammation 45 1 — Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS.

Human Endothelium as a Source of Multifunctional Cytokines: Molecular Regulation and Possible Role in Human Disease. J Interferon Cytokine Res 19 2 — Teijaro John R, Walsh Kevin B, Cahalan S, Fremgen Daniel M, Roberts E, Scott F, et al.

Endothelial Cells are Central Orchestrators of Cytokine Amplification During Influenza Virus Infection. Cell 6 — Pober JS, Merola J, Liu R, Manes TD.

Antigen Presentation by Vascular Cells. Front Immunol Joyce DE, Nelson DR, Grinnell BW. Leukocyte and Endothelial Cell Interactions in Sepsis: Relevance of the Protein C Pathway. Crit Care Med 32 5 Suppl :S—6. Nourshargh S, Alon R. Leukocyte Migration Into Inflamed Tissues. Immunity 41 5 — Krieglstein CF, Granger DN.

Adhesion Molecules and Their Role in Vascular Disease. Am J Hypertens 14 6 Pt 2 s—54s. Danese S, Dejana E, Fiocchi C.

Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation. J Immunol Baltimore Md 10 — Borkow G, Lomonte B, Gutierrez JM, Ovadia M.

Effect of Various Viperidae and Crotalidae Snake Venoms on Endothelial Cells In Vitro. Toxicon Off J Int Soc Toxinol 32 12 — Nowatzki J, de Sene RV, Paludo KS, Veiga SS, Oliver C, Jamur MC, et al. Brown Spider Venom Toxins Interact With Cell Surface and are Endocytosed by Rabbit Endothelial Cells.

Toxicon Off J Int Soc Toxinol 56 4 — Chung C-H, Wu W-B, Huang T-F. Aggretin, a Snake Venom—Derived Endothelial Integrin α2β1 Agonist, Induces Angiogenesis Via Expression of Vascular Endothelial Growth Factor.

Blood 6 — Paludo KS, Gremski LH, Veiga SS, Chaim OM, Gremski W, de Freitas Buchi D, et al. The Effect of Brown Spider Venom on Endothelial Cell Morphology and Adhesive Structures.

Toxicon Off J Int Soc Toxinol 47 8 — Delafontaine M, Villas-Boas IM, Mathieu L, Josset P, Blomet J, Tambourgi DV. Enzymatic and Pro-Inflammatory Activities of Bothrops Lanceolatus Venom: Relevance for Envenomation. Toxins 9 8 Patel KD, Modur V, Zimmerman GA, Prescott SM, McIntyre TM.

The Necrotic Venom of the Brown Recluse Spider Induces Dysregulated Endothelial Cell-Dependent Neutrophil Activation. Differential Induction of GM-CSF, Il-8, and E-selectin Expression. J Clin Invest 94 2 — Chiu S, Bharat A. Role of Monocytes and Macrophages in Regulating Immune Response Following Lung Transplantation.

Curr Opin Organ Transplant 21 3 — Randolph GJ, Jakubzick C, Qu C. Antigen Presentation by Monocytes and Monocyte-Derived Cells. Curr Opin Immunol 20 1 — Franken L, Schiwon M, Kurts C.

Macrophages: Sentinels and Regulators of the Immune System. Cell Microbiol 18 4 — Ma WT, Gao F, Gu K, Chen DK. The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review.

Sampaio SC, Sousa-e-Silva MC, Borelli P, Curi R, Cury Y. Crotalus Durissus Terrificus Snake Venom Regulates Macrophage Metabolism and Function. J Leukocyte Biol 70 4 —8. PubMed Abstract Google Scholar. Setubal SS, Pontes AS, Furtado JL, Kayano AM, Stábeli RG, Zuliani JP.

Effect of Bothrops Alternatus Snake Venom on Macrophage Phagocytosis and Superoxide Production: Participation of Protein Kinase C. J Venomous Anim Toxins Including Trop Dis 17 4 — Saadi S, Assarehzadegan MA, Pipelzadeh MH, Hadaddezfuli R. Induction of IL From Human Monocytes After Stimulation With Androctonus Crassicauda Scorpion Venom.

Toxicon Off J Int Soc Toxinol — Pires WL, Kayano AM, Castro OB, Paloschi MV, Lopes JA, Boeno CN, et al. J leukocyte Biol 3 — Rojas JM, Aran-Sekul T, Cortes E, Jaldín R, Ordenes K, Orrego PR, et al. Toxins 9 4 Zoccal KF, Ferreira GZ, Prado MKB, Gardinassi LG, Sampaio SV, Faccioli LH.

LTB4 and PGE2 Modulate the Release of MIP-1α and IL-1β by Cells Stimulated With Bothrops Snake Venoms. Khemili D, Valenzuela C, Laraba-Djebari F, Hammoudi-Triki D. Differential Effect of Androctonus Australis Hector Venom Components on Macrophage KV Channels: Electrophysiological Characterization.

Eur Biophys J 48 1 :1— Hsu C-C, Chuang W-J, Chung C-H, Chang C-H, Peng H-C, Huang T-F. Snake Venom Disintegrin Inhibits the Activation of Toll-Like Receptors and Alleviates Sepsis Through Integrin alphaVbeta3 Blockade.

Sci Rep Nature Publisher Group Zoccal KF, Bitencourt C, Paula-Silva FWG, CA S, de Castro Figueiredo Bordon K, Arantes EC, et al. Tlr2, TLR4 and CD14 Recognize Venom-Associated Molecular Patterns From Tityus Serrulatus to Induce Macrophage-Derived Inflammatory Mediators.

PloS One 9 2 :e—e. Veda P. Why are Neutrophils Polymorphonuclear? Eur J Inflammation 9 2 — Kruger P, Saffarzadeh M, Weber ANR, Rieber N, Radsak M, von Bernuth H, et al. Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury. PloS Pathog 11 3 :e Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER.

Neutrophil Kinetics in Health and Disease. Trends Immunol 31 8 — Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, et al. In Vivo Labeling With 2H2O Reveals a Human Neutrophil Lifespan of 5. Blood 4 —7. Tecchio C, Micheletti A, Cassatella MA. Neutrophil-Derived Cytokines: Facts Beyond Expression.

Rorvig S, Ostergaard O, Heegaard NH, Borregaard N. Proteome Profiling of Human Neutrophil Granule Subsets, Secretory Vesicles, and Cell Membrane: Correlation With Transcriptome Profiling of Neutrophil Precursors.

J leukocyte Biol 94 4 — Papayannopoulos V. Neutrophil Extracellular Traps in Immunity and Disease. Nat Rev Immunol 18 2 — Kaplan MJ, Radic M. Neutrophil Extracellular Traps: Double-edged Swords of Innate Immunity.

J Immunol Baltimore Md 6 — Katkar GD, Sundaram MS, NaveenKumar SK, Swethakumar B, Sharma RD, Paul M, et al.

Netosis and Lack of DNase Activity are Key Factors in Echis Carinatus Venom-Induced Tissue Destruction. Nat Commun Stackowicz J, Balbino B, Todorova B, Godon O, Iannascoli B, Jönsson F, et al. Evidence That Neutrophils do Not Promote Echis Carinatus Venom-Induced Tissue Destruction.

Nat Commun 9 1 Williams DJ, Faiz MA, Abela-Ridder B, Ainsworth S, Bulfone TC, Nickerson AD, et al. Strategy for a Globally Coordinated Response to a Priority Neglected Tropical Disease: Snakebite Envenoming. PloS Negl Trop Dis 13 2 :e Krystel-Whittemore M, Dileepan KN, Wood JG.

Mast Cell: A Multi-Functional Master Cell. Galli SJ, Starkl P, Marichal T, Tsai M. Allergology Int Off J Japanese Soc Allergology 65 1 :3— Rivera J, Gilfillan AM. Molecular Regulation of Mast Cell Activation. J Allergy Clin Immunol 6 — Moon TC, Befus AD, Kulka M.

Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved. Gilfillan AM, Tkaczyk C. Integrated Signalling Pathways for Mast-Cell Activation. Nat Rev Immunol 6 3 — Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of Mast Cell Signaling in Anaphylaxis.

J Allergy Clin Immunol 4 — Galli SJ, Tsai M. Ige and Mast Cells in Allergic Disease. Nat Med 18 5 — Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms. Trans Am Clin Climatological Assoc — Pejler G, Rönnberg E, Waern I, Wernersson S.

Mast Cell Proteases: Multifaceted Regulators of Inflammatory Disease. Blood 24 — Fehervari Z. Mast Cells Crack Down on Venom. Nat Immunol 12 12 —. Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins From IL-1 to IL , Interferons, Transforming Growth Factor Beta, and TNF-alpha: Receptors, Functions, and Roles in Diseases.

Miller MC, Mayo KH. Chemokines From a Structural Perspective. Int J Mol Sci 18 10 Oppenheim JJ, Matsushima K, Yoshimura T, Leonard EJ. The Activities of Cytokines are Pleiotropic and Interdependent. Immunol Lett 16 — Ozaki K, Leonard WJ. Cytokine and Cytokine Receptor Pleiotropy and Redundancy.

J Biol Chem 33 —8. Aikawa N. Cytokine Storm in the Pathogenesis of Multiple Organ Dysfunction Syndrome Associated With Surgical Insults.

Nihon Geka Gakkai zasshi 97 9 —7. Bown MJ, Nicholson ML, Bell PR, Sayers RD. Cytokines and Inflammatory Pathways in the Pathogenesis of Multiple Organ Failure Following Abdominal Aortic Aneurysm Repair.

Eur J Vasc endovascular Surg Off J Eur Soc Vasc Surg 22 6 — De Gaudio AR, Romagnoli S. Sepsis and Septic Shock , Eighth ed. China: Elsevier Health Sciences Lipnik-Stangelj M. Mediators of Inflammation as Targets for Chronic Pain Treatment. Mediators Inflammation —.

Zhang J-M, An J. Cytokines, Inflammation, and Pain. Int Anesthesiol Clin 45 2 — Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory Responses and Inflammation-Associated Diseases in Organs. Oncotarget 9 6 — Robinson SM, Rasch S, Beer S, Valantiene I, Mickevicius A, Schlaipfer E, et al.

Systemic Inflammation Contributes to Impairment of Quality of Life in Chronic Pancreatitis. Sci Rep 9 1 Henden AS, Hill GR.

Cytokines in Graft-Versus-Host Disease. J Immunol 10 Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the Eye of the Cytokine Storm. Microbiol Mol Biol Rev 76 1 — White M.

Mediators of Inflammation and the Inflammatory Process. J Allergy Clin Immunol 3 :S—S Stone SF, Isbister GK, Shahmy S, Mohamed F, Abeysinghe C, Karunathilake H, et al. Immune Response to Snake Envenoming and Treatment With Antivenom; Complement Activation, Cytokine Production and Mast Cell Degranulation.

PloS Neglected Trop Dis 7 7 :e Ibiapina HNS, Costa AG, Sachett JAG, Silva IM, Tarrago AM, Neves JCF, et al. An Immunological Stairway to Severe Tissue Complication Assembly in Bothrops Atrox Snakebites. Markland FS. Snake Venoms and the Hemostatic System.

Toxicon Off J Int Soc Toxinol 36 12 — Luchini LSG, Pidde G, Squaiella-Baptistão CC, Tambourgi DV. Complement System Inhibition Modulates the Pro-Inflammatory Effects of a Snake Venom Metalloproteinase. Rider P, Carmi Y, Cohen I. Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Int J Cell Biol —. Zoccal KF, Gardinassi LG, Bordon KCF, Arantes EC, Marleau S, Ong H, et al. EP Restrains Inflammation and Mortality Caused by Scorpion Envenomation in Mice.

Front Pharmacol Dalla-Favera R, Klein U. Germinal Centres: Role in B-cell Physiology and Malignancy. Nat Rev Immunol 8 1 — Koretzky GA. Multiple Roles of CD4 and CD8 in T Cell Activation. J Immunol 5 —4. Parker DC. T Cell-Dependent B Cell Activation. Annu Rev Immunol 11 1 — Harwood NE, Batista FD.

Early Events in B Cell Activation. Annu Rev Immunol 28 1 — Restano-Cassulini R, Garcia W, Paniagua-Solís J, Possani L. Annex 5: Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins: Replacement of Annex 2 of WHO Technical Report Series, No.

World Health Organization Report No. Fox S, Rathuwithana AC, Kasturiratne A, Lalloo DG, de Silva HJ. Underestimation of Snakebite Mortality by Hospital Statistics in the Monaragala District of Sri Lanka. Trans R Soc Trop Med Hygiene 7 —5. Gilliam LL, Carmichael RC, Holbrook TC, Taylor JM, Ownby CL, McFarlane D, et al.

Antibody Responses to Natural Rattlesnake Envenomation and a Rattlesnake Toxoid Vaccine in Horses. Clin Vaccine Immunol 20 5 —7. Casadevall A. Passive Antibody Administration Immediate Immunity as a Specific Defense Against Biological Weapons.

Emerg Infect Dis 8 8 — Restano-Cassulini R, Garcia W, Paniagua-Solis JF, Possani LD. Antivenom Evaluation by Electrophysiological Analysis. Toxins 9 3 Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Immunol Rev 1 — Magee CN, Boenisch O, Najafian N.

The Role of Costimulatory Molecules in Directing the Functional Differentiation of Alloreactive T Helper Cells. Am J Transplant 12 10 — Vazquez MI, Catalan-Dibene J, Zlotnik A. B Cells Responses and Cytokine Production are Regulated by Their Immune Microenvironment.

Cytokine 74 2 — Shlomchik MJ, Weisel F. Germinal Center Selection and the Development of Memory B and Plasma Cells. Khan U, Ghazanfar H.

T Lymphocytes and Autoimmunity. Int Rev Cell Mol Biol — Rangel-Santos A, Lima C, Lopes-Ferreira M, Cardoso DF. Immunosuppresive Role of Principal Toxin Crotoxin of Crotalus Durissus Terrificus Venom. Toxicon Off J Int Soc Toxinol 44 6 — Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G, et al.

Targeting Effector Memory T Cells With a Selective Peptide Inhibitor of Kv1. Mol Pharmacol 67 4 — Bencherif M, Lippiello PM, Lucas R, Marrero MB.

Alpha7 Nicotinic Receptors as Novel Therapeutic Targets for Inflammation-Based Diseases. Cell Mol Life Sci 68 6 — Bagdány M, Batista CVF, Valdez-Cruz NA, Somodi S, Rodriguez De La Vega RC, Licea AF, et al.

Anuroctoxin, a New Scorpion Toxin of the α-KTx 6 Subfamily, is Highly Selective for Kv1. Waheed H, Moin SF, Choudhary MI. Snake Venom: From Deadly Toxins to Life-Saving Therapeutics.

Curr Med Chem 24 17 — Pennington MW, Czerwinski A, Norton RS. Peptide Therapeutics From Venom: Current Status and Potential. Bioorg Med Chem 26 10 — Bogin O. Venom Peptides and Their Mimetics as Potential Drugs. Modulator — Pineda SS, Undheim EA, Rupasinghe DB, Ikonomopoulou MP, King GF. Spider Venomics: Implications for Drug Discovery.

Fut Med Chem 6 15 — King GF. Venoms as a Platform for Human Drugs: Translating Toxins Into Therapeutics. Expert Opin Biol Ther 11 11 — Ryan RYM, Lutzky VP, Herzig V, Smallwood TB, Potriquet J, Wong Y, et al.

Venom of the Red-Bellied Black Snake Pseudechis Porphyriacus Shows Immunosuppressive Potential. Toxins 12 11 Welton RE, Williams DJ, Liew D. Injury Trends From Envenoming in Australia, — Internal Med J 47 2 —6.

Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in Anaphylaxis Fatalities in Australia From to Clin Exp Allergy 46 8 — Pesek RD, Lockey RF.

Management of Insect Sting Hypersensitivity: An Update. Allergy Asthma Immunol Res 5 3 — Bilò MB. Anaphylaxis Caused by Hymenoptera Stings: From Epidemiology to Treatment. Allergy 66 95 —7. Curotto de Lafaille MA, Lafaille JJ, Graça L. Mechanisms of Tolerance and Allergic Sensitization in the Airways and the Lungs.

Curr Opin Immunol 22 5 — Ollert M, Blank S. Anaphylaxis to Insect Venom Allergens: Role of Molecular Diagnostics. Curr Allergy Asthma Rep 15 5 —.

Janeway C, National Library of M. Immunobiology: The Immune System in Health and Disease. Fifth ed. New York: Garland Pub van Ree R, Hummelshøj L, Plantinga M, Poulsen LK, Swindle E. Allergic Sensitization: Host-immune Factors.

Clin Trans Allergy 4 1 Ellenbogen Y, Jiménez-Saiz R, Spill P, Chu DK, Waserman S, Jordana M. The Initiation of Th2 Immunity Towards Food Allergens. Int J Mol Sci 19 5 Thangam EB, Jemima EA, Singh H, Baig MS, Khan M, Mathias CB, et al.

The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets. Front Immunol 9 Stitt JMD, Katial RMD. Venom Allergy. Information about devaccination continues to circulate on some platforms, such as BitChute and Telegram.

multiply and form independent neural networks inside those who have received COVID vaccines and could ultimately influence their thoughts and actions.

Now, we have to worry about jellyfish controlling our minds? Photo: Shutterstock. Even though sometimes we want to believe that someone has found the cure or answer to a question we are seeking, go with your gut reaction. If it sounds ridiculous, it probably is.

If you are unsure whether the information is legitimate, talk to a family member, friend or your GP. Using the cupping video as an example, Stephen Dickey, a professor of Slavic languages and literature at the University of Kansas, identified the dialogue in the video as Russian.

When reviewing the resource, do you know who the author is and does that author specialise in the field the article is concerned with? Check LinkedIn or do a quick Google search to see if the author can speak about the subject with authority and accuracy. Have you considered whether the person or organisation attempting to sell you a new drug or treatment has a hidden agenda?

This can be increasing their reach on social media or making money. The post about the snakebite kit included references to three published papers. These were dated , decades before COVID. In the case of the paper, this looked at measures for a particular type of snakebite , which included examining the effects of applying firm crepe bandages on monkeys.

Moreover, Phα1β and its recombinant version were able to reduce the inflammatory phase of the formalin-induced nociceptive behavior in rats, to decrease neuropathic pain caused by chronic constriction injury of sciatic nerve in rats, and to reduce the hyperalgesia caused by melanoma cancer model in mice Rigo et al.

nigriventer venom became attractive because of its induced-priapism effect. Interestingly, a minimum dose of 0. PnPP is a promising candidate for erectile dysfunction treatment in patients that do not respond to the usual therapies Silva et al.

Biozeus Biopharmaceutical S. A performed pilot tests with the topical peptide renamed BZ on healthy human beings and has been performing a pilot test with voluntary men with erectile dysfunction associated to hypertension or diabetes.

The regulatory toxicological preclinical tests have already started. org , their therapeutic use are limited due to their susceptibility to proteolysis. Tetrodotoxin TTX , a guanidinium neurotoxin with high affinity for voltage-gated sodium Na v channels, had traditionally been known for many years as the main toxin from Tetraodontidae pufferfish Lago et al.

However, the toxin was present not only in other marine animals such as octopuses, gobies and sea stars, but also in phylogenetically unrelated terrestrial and aquatic organisms, including a dinoflagellate Alexandrium tamarense , red calcareous algae, arthropods, echinoderms, molluscs, worms, newts, frogs, and bacteria Actinomyces , Aeromonas , Alteromonas , Bacillus and Pseudomonas Lago et al.

TTX has been used for the development of analgesic and anesthetic drugs Assuncao et al. The salivary secretion from different animals, such as bats, leeches, lizards, shrews and ticks are considered important sources of biologically active compounds.

Other animals, such as caterpillars, have biologically active compounds in their bristles. Many of these compounds are still underexploited, lacking information on their chemical structure, physiological role and therapeutic application.

Thus, the study of these compounds increases the chances of discovering new compounds with great pharmaceutical potential. The subsections Bats to Ticks will address some potential therapeutic molecules found in the saliva or bristles of these animals. This fibrin-dependent plasminogen activator is composed of amino acids with high fibrin specificity, long half-life, low bleeding tendency, nonactivation by β-amyloid and lack of neurotoxicity Medcalf, ; Shi et al.

A phase III randomized study in participants with acute ischemic stroke was completed in Currently, there is no drug based on desmoteplase available for commercialization. Caterpillars from different South American countries, such as Venezuela, Brazil, French Guyana, Peru, Paraguay, Argentina and Colombia, are responsible for a severe bleeding syndrome in humans who touch their bristles Arocha-Pinango and Guerrero, Lonomia obliqua is the main species of caterpillar found in Southern Brazil and its venom is comprised of molecules with antiviral, procoagulant, fibrinolytic and wound healing activities Veiga et al.

Their toxic compounds are found in the bristle extract, hemolymph, cryosecretion a crude venomous fluid ejected by the whole secretory tegument of caterpillars, stored at °C for 24 h and tegument extract Pinto et al. Some compounds with potential therapeutic applications were identified in Lonomia sp, e.

prothrombin or factor X activators, such as Lopap L. obliqua prothrombim activator protease and Losac L. obliqua Stuart factor activator protease , PLA 2 -like, proteases, hyaluronidases, α-fibrinogenases e. Lonofibrase , protease inhibitors, serpins, lipocalins, and lectins Veiga et al. Currently, there are three clinical studies on caterpillars recorded at the Clinical Trials website US National Library of Medicine, However, these studies are related to their use as a source of protein in the diet and none of them involves the genus Lonomia.

Two phase II randomized studies involving leech therapy in NCT and 60 participants NCT with knee osteoarthritis were completed in and , respectively. Additional information on FDA-approved hirudin analogues from H.

medicinalis leech saliva and hirudotherapy was reported in section Achievements With Animal Toxin-Based Molecules. Exenatide is the synthetic version of the native peptide exendin-4 isolated from the saliva of Gila monster lizard H.

suspectum Eng et al. According to the Clinical Trials website, there are more than clinical studies about exenatide. So far, there are completed studies, 12 terminated, 25 whose status has not changed for 2 years, 47 recruiting volunteers, 11 that are not yet recruiting, and three enrolled by invitation.

For an extensive review regarding clinical trials involving this drug, please see Odegard and Desantis, ; Bhavsar et al.

Additional information on exenatide was described in section Achievements With Animal Toxin-Based Molecules. SOR-C13 is a synthetic selective peptide inhibitor of Transient Receptor Potential Vanilloid 6 TRPV6 calcium oncochannel Pennington et al.

It is comprised of 13 amino acids derived from the C-terminal region of the paralytic peptide soricidin UniProtKB—P0C2P6 , from the submaxillary and sublingual salivary glands of the Northern Short-tailed shrew Blarina brevicauda Bowen et al.

It inhibits the activation of nuclear factor of activated T-cell NFAT transcription complex, and induces apoptosis in TRPV6-overexpressing cells NIH National Cancer Institute, A phase I of study NCT in 23 advanced cancer patients with TRPV6 channel overexpression was completed in and a phase I study NCT started recruiting patients with advanced refractory solid tumors in There are several studies addressing the importance of tick saliva components.

The use of evasins in the treatment of heart diseases, such as myocarditis Singh et al. However, although tick saliva contains many components with therapeutic and biotechnological potentials, there are neither clinical studies involving the use of substances isolated from tick saliva nor drugs available for therapeutic purposes.

The clinical studies currently registered on the Clinical Trial website in respect to ticks are related to the development of vaccines against ticks or the use of different antibiotics in Lyme disease. Animal poisons and venoms are comprised of a cocktail of bioactive components with a gamut of different activities.

Company pipelines worldwide are expanding the number of peptide-based products currently in development mainly because of the diversity of their application and activity.

However, industrial production of toxin-related drugs from natural sources is quite challenging, laborious and presents restricted yield Boldrini-França et al. To overcome these limitations, the main options are the chemical synthesis of peptides and the production of biopharmaceuticals via heterologous expression using biotechnological tools.

Recent data reinforces the advances in transcriptomics, proteomics and heterologous expression techniques, which allowed the characterization and potential production of low abundant active venom components, presenting low or high molecular mass Boldrini-França et al.

The industry has focused on heterologous expression systems as an interesting alternative for manufacturing biopharmaceuticals of high molecular mass Merlin et al. Recombinant protein production processes require extensive design and regulatory control before therapeutic products become commercially available.

Regarding heterologous expression, the accurate cysteine bond formation and the proper incorporation of post-translational modifications remain a challenge, and new technologies to assess and mitigate immunogenicity risk of engineered proteins are becoming more common.

Therefore, a special attempt should be made to ensure that the recombinant protein presents comparable three-dimensional folding and consistent pharmacological properties when compared to its corresponding native form.

Native chemoselective reaction has been employed in the production of animal toxins with potential therapeutic application, such as mambalgin-2, a amino acid analgesic peptide from three-finger toxins family, from Dendroaspis polylepis polylepis venom Diochot et al. This approach allows the synthesis of large proteins, since it is based in the production of different unprotected linear peptide fragments, which are condensed in solution via chemoselective reactions to originate the entire polypeptide Kent et al.

Studies to improve the protecting groups, resins, linkers, and activation and coupling reagents may enable the manufacture of larger peptides and even small proteins for therapeutic applications.

However, the development of cheaper reagents and methods for the synthesis and purification of peptides are necessary. Concerning the limitations of peptides in terms of their biopharmaceutical properties, designed approaches that will find molecules with intrinsically more favorable properties will need to be devised.

As mentioned earlier in section Achievements With Animal Toxin-Based Molecules , the drug design of captopril made oral administration possible.

Additionally, designed cationicity-enhanced analogues of natural antimicrobial peptides have exhibited higher potency and spectra of antimicrobial activity Luna-Ramirez et al.

Achievements towards successful oral delivery of proteins and peptides by protecting them against degradation and increasing their absorption remain as an active area of research. Regarding toxin-based formulations, intranasal inoculation of hyaluronidase from T.

serrulatus venom induced mononuclear increase in the bronchoalveolar space and became a promising tool for the treatment of pulmonary fibrosis Bitencourt et al. Some approaches to improve biopharmaceuticals delivery, such as alternative delivery routes, PEGylation and conjugation to nano carriers, represent a relevant step towards targeted delivery of toxin-based drugs.

It is sobering to realize how little alternative delivery routes and bioconjugation strategies have been exploited to deliver toxin-based drugs, suggesting that studies on routes of distribution, delivery vehicles, cargo molecules, and targeting strategies are fruitful fields for future research.

Collinein-1, a thrombin-like serine protease from C. collilineatus , was successfully modified by site-specific PEGylation with maleimide-mPEG of 5 kDa and exhibited higher catalytic efficiency and affinity for the substrate than the native form da-Silva-Freitas et al.

The PEGylated peptide HsTX1[R14A] from Heterometrus spinnifer scorpion venom showed higher plasma circulating half-life in rodents compared to the native peptide, which resulted in sustained efficacy in rodent models of multiple sclerosis and rheumatoid arthritis Tanner et al.

In the drug development process, formulation patents using advanced drug release systems extend the market exclusivity of drugs, because of the high technical barrier to be overcome by generic manufacturers after the expiration of patents.

Focusing on competitiveness, pharmaceutical companies have established strategic partnerships with leading academic institutions that have deep scientific expertise in novel concepts in the main areas of biology or chemistry. Some reports have shown the antitumor potential, among other applications, of animal venoms or their toxins conjugated with a wide variety of nanomaterials, such as silica, gold, chitosan, poly D,L-Lactide -based, and supermagnetic iron oxide nanoparticles Badr et al.

Studies on cell penetrating peptides CPPs have open unprecedented possibilities for vector applications in several fields, such as basic research, therapeutics, technology, and medical imaging. serrulatus venom, showed to be a potential intranuclear delivery tool to target cancerous cells de Oliveira-Mendes et al.

WaTx, a cell-penetrating toxin from the Australian black rock scorpion U. Another field in ever-growing demand is the cosmeceutical industry, especially in Asia, where Korea is at the forefront of cosmeceutical development.

Efficacy and safety studies on these products in humans are on high demand Juhász et al. Animal poisons and venoms are rich sources of molecules with a wide range of applications. However, to make the use of these molecules feasible, extensive preclinical trials are necessary, with some applications also requiring clinical trials Figure 2.

Figure 2 Animal poisons and venoms as sources of candidate molecules for wide-ranging applications, after extensive characterization during preclinical and clinical trials.

Although the research in the field of toxinology tends to be quite challenging and time-consuming, the high selectivity of animal toxins for their targets turns them into promising leads for the development of effective therapeutic drugs. Studies on new engineered molecules with reduced side effects can be reached by untangling the interaction of venom peptides with their target.

Therefore, we are still at a beginning phase in comprehending the complexity of animal venoms and poisons. While very few species have been extensively studied, we still have thousands of unexploited organisms, especially marine ones.

Novel methods to produce and deliver biopharmaceuticals are expected to be developed in the near future. With that in mind, we can get a glimpse of how much work on toxinology and drug discovery is yet to come in the next years.

KB and EA contributed to the conception and design of the study. KB and EP-J wrote the first draft of the manuscript. KB, CC, EF-B, EP-J, FCe, FGA, FPA, FCo, GW, IC, IF, IO, JB-F, MP, MB, and EA wrote sections of the manuscript.

FCe created the figures. KB, GW, IC, and IO created the tables. All authors contributed to manuscript revision, read, and approved the submitted version. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abdualkader, A. Leech therapeutic applications. Indian J. doi: PubMed Abstract CrossRef Full Text Google Scholar. Accardo, A. Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor GRP-R ligands for in vivo targeting of receptor-expressing tumors.

EJNMMI Res. Adis Insight Google Scholar. Ali, M. Studies on bee venom and its medical uses. Alvarez-Flores, M. Losac, the first hemolin that exhibits procogulant activity through selective factor X proteolytic activation.

Alves, P. Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster. Toxicon , 1— Andrade, E. Penile erection induced in vivo by a purified toxin from the Brazilian spider Phoneutria nigriventer. BJU Int. Arocha-Pinango, C.

Lonomia genus caterpillar envenomation: Clinical and biological aspects. Haemostasis 31 , — Assuncao, J. Biotechnological and pharmacological applications of biotoxins and other bioactive molecules from dinoflagellates. Drugs 15 12 , CrossRef Full Text Google Scholar. Badr, G.

Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles.

Cell Physiol. Baratto, L. Prostate cancer theranostics targeting gastrin-releasing peptide receptors. Imaging Biol. Barros, L. A new fibrin sealant from Crotalus durissus terrificus venom: applications in medicine.

Health B Crit. Bastos, E. Bayer Healthcare Discontinuation of Refludan® [lepirudin rDNA for injection]. pdf Accessed March 19, Beeton, C.

Kastin, A. Amsterdam: Elsevier , — Bhavsar, S. Evolution of exenatide as a diabetes therapeutic. Diabetes Rev. Biocentury Pepteron RPI-MN. Biollaz, J. Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I.

Biozeus Biopharmaceutical SA First clinical trial sponsored by Biozeus concluded! Bitencourt, C. Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis.

Fibrogenesis Tissue Repair 4 1 , 3. Bittl, J. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study.

Heart J. Boldrini-França, J. Expression of a new serine protease from C rotalus durissus collilineatus v enom in P ichia pastoris and functional comparison with the native enzyme.

Minor snake venom proteins: Structure, function and potential applications. Acta Gen. Boldrini-Franca, J. Functional and biological insights of rCollinein-1, a recombinant serine protease from C rotalus durissus collilineatus. Toxins Incl.

Beyond hemostasis: a snake venom serine protease with potassium channel blocking and potential antitumor activities. Bonifazi, F. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 60 12 , — Bowen, C. I n vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin.

PloS One 8 3 , e Braud, S. Snake venom proteins acting on hemostasis. Biochimie 82 , — Bressan, E. Crotalphine desensitizes TRPA1 ion channels to alleviate inflammatory hyperalgesia.

Pain 11 , — Brigatte, P. Peripheral kappa and delta opioid receptors are involved in the antinociceptive effect of crotalphine in a rat model of cancer pain.

Brinkhous, K. Botrocetin venom coagglutinin - Reaction with a broad-spectrum of multimeric forms of factor VIII macromolecular complex. Brogden, R. Captopril - an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart-failure.

Drugs 36 5 , — Brust, A. χ-conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor Xen for pain. Buchaim, D. Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review.

Burkhart, W. Amino acid sequence determination of ancrod, the thrombin-like alpha-fibrinogenase from the venom of A gkistrodon rhodostoma. FEBS Lett. Butte, P. Near-infrared imaging of brain tumors using the Tumor Paint BLZ to achieve near-complete resection of brain tumors.

Focus 36 2 , E1. Camargo, A. Bradykinin-potentiating peptides: Beyond captopril. Toxicon 59 4 , — Carmo, A. Discovery of a new antiviral protein isolated L onomia obliqua analysed by bioinformatics and real-time approaches.

Cytotechnology 67 6 , — Cescato, R. Bombesin receptor antagonists may be preferable to agonists for tumor targeting. Chan, Y. Snake venom toxins: toxicity and medicinal applications. Chang, C. Involvement of acid-sensing ion channel 1b in the development of acid-induced chronic muscle pain.

Chassagnon, I. Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Chen, C. A single-label fluorescent derivatization method for quantitative determination of neurotoxin i n vivo by capillary electrophoresis coupled with laser-induced fluorescence detection.

Analyst 14 , — Chow, S. Adaptive design methods in clinical trials - a review. Orphanet J. Rare Dis. Christensen, M. Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.

Idrugs 12 8 , — PubMed Abstract Google Scholar. Clark, R. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Ed 49 37 , — Clark, G. Friends or foes? Emerging impacts of biological toxins. Trends Biochem. Cohen-Inbar, O. Glioblastoma multiforme targeted therapy: The Chlorotoxin story.

Cooper, E. Exploiting leech saliva to treat osteoarthritis: A provocative perspective. Complement Med. Cushman, D. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

Biochemistry 16 25 , — Daly, J. Chlorine compound of the month: Eptibatidine - natural frog poison with a surprising benefit to humans. Das Gupta, S. Indian black scorpion H eterometrus bengalensis Koch venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U and K da-Silva-Freitas, D.

PEGylation: A successful approach to improve the biopharmaceutical potential of snake venom thrombin-like serine protease. Protein Pept. de Azevedo, R. Mastoparan induces apoptosis in B1 6FNex2 melanoma cells via the intrinsic mitochondrial pathway and displays antitumor activity i n vivo.

Peptides 68, — de Oliveira-Mendes, B. CPP-Ts: a new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells. DeBin, J. Chloride channel inhibition by the venom of the scorpion L eiurus quinquestriatus. Toxicon 29 11 , — Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion.

DeYoung, M. Encapsulation of exenatide in poly- D,L-lactide-co-glycolide microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes.

Diabetes Technol. Ding, J. Scorpion venoms as a potential source of novel cancer therapeutic compounds. Maywood 4 , — Diochot, S.

Black mamba venom peptides target acid-sensing ion channels to abolish pain. Nature , — Dodt, J. The complete amino acid sequence of hirudin, a thrombin specific inhibitor. Application of colour carboxymethylation. FEBS 2 , — Drug discovery and development Nutra Pharma announces manufacturing alliance with Omnia Biologics to produce RPIM for clinical trials in pediatric multiple sclerosis.

com Duran-Riveroll, L. Guanidinium toxins and their interactions with voltage-gated sodium ion channels. Mar Drugs 15 10 , Duskey, J. Current strategies for the delivery of therapeutic proteins and enzymes to treat brain disorders. Earps, L. Molecular modelling of batroxobin on kallikreins.

Elkinson, S. Lixisenatide: First global approval. Drugs 73 4 , — Eng, J. Isolation and characterization of exendin-4, an exendin-3 analogue, from H eloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.

Eriksson, U. Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects. Esteve, E. Transduction of the scorpion toxin maurocalcine into cells - Evidence that the toxin crosses the plasma membrane.

European Medicines Agency Search for medicines: Search our database of medicines - including human medicines, veterinary medicines and herbal medicines. Favaloro, E. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines.

Pathology 46 6 , — Ferrajolo, C. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf. Ferreira, S.

Potentiation of bradykinin and eledoisin by BPF bradykinin potentiating factor from Bothrops jararaca venom. Experientia 21 6 , — Isolation of bradykinin-potentiating peptides from B othrops jararaca venom. Biochemistry 9 13 , — Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme.

Ferreira, R. Heterologous fibrin sealant derived from snake venom: from bench to bedside - an overview. A bradykinin-potentiating factor BPF present in the venom of B othrops jararaca.

Angiotensin converting enzyme: history and relevance. Fox, J. Approaching the golden age of natural product pharmaceuticals from venom libraries: An overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications.

Francischetti, I. Shaz, B. Fu, Y. Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. A potential strategy for high-grade gliomas: combination treatment with lithium chloride and BmK CT.

Fu, S. First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. New Drugs 35 3 , — Funk, C. Reptilase® - a new reagent in blood coagulation.

Furman, B. The development of Byetta exenatide from the venom of the Gila monster as an anti-diabetic agent. Gajski, G. Melittin: A lytic peptide with anticancer properties. Gan, Z. A potent platelet aggregation inhibitor from the venom of the viper E chis carinatus.

Gao, B. Cone snails: a big store of conotoxins for novel drug discovery. Toxins 9 12 Gazerani, P. Venom-based biotoxins as potential analgesics. Expert Rev. Ghosh, A. Scorpion venom-toxins that aid in drug development: a review.

Gomes, A. Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules 22 10 , Gotter, A. Graetz, T. Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis.

Graziano, F. Autologous fibrin sealant Vivostat® in the neurosurgical practice: Part I: Intracranial surgical procedure. Aulogous fibrin sealant Vivostat® in the neurosurgical practice: Part II: Vertebro-spinal procedures. Greig, N.

This study aimed defoxification evaluate the clinical therapeutic efficacy of anti-snake venom Snake venom detoxification methods blockade vdnom treating local Snake venom detoxification methods necrosis caused methodx Chinese cobra Naja Liver detoxification methods bites. The experimental setoxification received Snake venom detoxification methods as Snke as anti-snake venom serum blocking treatment, genom regular treatment plus chymotrypsin blocking therapy was given detoxirication the control group. The necrotic volumes around snake wounds in these groups were detected on the first, third and seventh days. On the third day of treatment, some local tissues in the wounds were randomly selected for pathological biopsy, and the necrosis volume of the local tissue was observed. Furthermore, the amount of time required for wound healing was recorded. Moreover, the pathological biopsies taken from the control group showed nuclear pyknosis, fragmentation, sparse nuclear density, and blurred edges, and the degree of necrosis was much higher than that of the experimental group. Anti-snake venom blocking therapy is a new and improved therapy with good clinical effect on local tissue necrosis caused by Chinese cobra bites; moreover, it is superior to conventional chymotrypsin blocking therapy in the treatment of cobra bites.

Snake venom detoxification methods -

When a compound is irradiated in a solution, the indirect effect joins the direct 9. Since water is the most abundant constituent of biological material, it is important to consider the species produced by excitation and ionization of water itself, and the reaction of these species with the target molecules of biological importance.

This indirect effect results from the reactions among the studied molecules and the products of radiation interaction with water or other solvents.

Highly reactive compounds, the so-called free radicals, which are formed undergo many reactions among themselves, with the dissolved gas, and with other molecules in the solution. With water, the excitation is less important than ionization which is followed within picoseconds by the formation of free hydroxyl radicals and hydrated electrons 2,4, With these results, it would be possible to use of ionizing radiation to change those protein molecules in order to improve some of their properties according to the necessity.

On the other hand, it is recognized that venoms in general are poorly immunogenic, yet fairly toxic This causes problems because serotherapy is the treatment of choice in snakebite envenomations, and horse antivenom availability is dependent upon immunogenicity.

KEY WORDS: Detoxification of snake venom, ionizing radiation, gamma rays. To improve antivenom production and extend the useful life of immunized horses effort has been devoted to decrease chronic venom toxicity 5,6,7,8,11,12,17,18, 20, Thus, once snake venoms are rich in proteins, Lauhatirananda et al.

They reported that irradiated venoms presented low toxicity, and that when the samples were in a dry state, the suitable irradiation dose to attenuate toxicity was higher than that used to samples in aqueous form.

In addition, Kankonkar et al. Few years later, Herrera et al. Murata et al. Following these studies Guarnieri 10 , used gamma rays to detoxify Bothrops jararaca venom. As found to Crotalus durissus terrificus venom, 2, Gy was the necessary dose to get the detoxification with maintenance of immunological properties observed through results of immunodiffusion, immunoblotting, immunoprecipitation, immunization of mice and rabbits and neutralization tests.

In addition, it was observed through proteolytic, hemorrhagic, coagulant and edema-forming activities, gel filtration and electrophoresis some conformational and structural alterations, protein aggregate formation and attenuation of tested activities. Furthermore, the animals immunized with irradiated venom presented no cutaneous lesion which is very common when Bothrops jararaca venom is injected.

More recently, Nascimento manuscript submitted to Toxicon has worked with crotoxin, main toxin of Crotalus durissus terrificus venom, in order to study the effects of gamma rays on purified toxin. Irradiation of crotoxin resulted in an aggregation and a generation of lower molecular weight breakdown products.

The high molecular weight aggregates were isolated by gel filtration and its immunological, biological and biochemical properties were analyzed. The aggregates presented no toxicity, no phospholipase activity and no ability to promote creatine kinase CK release into muscle tissue.

On the other hand, these aggregates were highly antigenic and were able to induce antibody formation in mice which cross-reacted with non irradiated crotoxin. In addition, mice immunized with aggregated immunogen survived a challenge of 15 LD50 of non irradiated crotoxin.

When biodistribution experiments were developed in mice, using labeled crotoxin with I, it could be observed that irradiated crotoxin was poorly retained in tested organs liver, muscle, spleen, kidneys, lungs, heart and brain , mainly in kidneys where no retention was observed.

Nascimento suggests that this results indicate ionizing radiation as a good tool in the detoxification process, highlighting out the aggregates as the ideal immunogen to be used during the immunization process to get snake antivenom without damage to the serum-productor animals.

Considering these promising results, other snake venoms have been studied in our laboratory such as Bothrops jararacussu, Lachesis muta venom and some experiments also were made with bee venom with good results of attenuation of toxicity when submitted to the effects of gamma rays.

Open menu Brazil. CN Song, Mei; Jiangxi University of Traditional Chinese Medicine. Science and Technology College. CN Li, Qiang; Jiangxi University of Traditional Chinese Medicine.

CN Chen, Jun; Jiangxi University of Traditional Chinese Medicine. CN Chen, Qi; Jiangxi University of Traditional Chinese Medicine. CN Liu, Liang; Jiangxi University of Traditional Chinese Medicine.

CN Wang, Xi; Jiangxi University of Traditional Chinese Medicine. CN Huang, Xiuqin; Jiangxi University of Traditional Chinese Medicine. Large nodes represent proteins with a known or predicted 3D structure.

The weight of edges indicates the confidence score, wherein a thicker line indicates stronger association. Protein-protein interactions are represented by a gray edge, while chemical-protein interactions are depicted in green.

Snakebites from highly venomous species can be fatal [ 4 4. Alirol E, Sharma SK, Bawaskar HS, Kuch U, Chappuis F. Snake bite in South Asia: a review. Gutierrez JM. Snakebite envenoming from an Ecohealth perspective.

Toxicon X. It is often difficult to find the appropriate antivenom for optimal clinical management, due to the misidentification of the snake species. Previously, there was a lack of careful studies investigating the protein profiles of the serum from snakebite patients.

Thus, we used label-free protein expression profiling to identify potential protein biomarkers in the serum of patients bitten by four different snake species. We found that one candidate compound, hydrogen peroxide, was highly associated with many proteins in the interaction network of proteins and drug compounds.

The label-free method is an effective technique for the simultaneous identification and quantification of thousands of proteins, providing potential biomarkers in a highly focused pool [ 29 Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE. Label-free LC-MS method for the identification of biomarkers.

Qian WJ, Jacobs JM, Liu T, Camp DG 2nd, Smith RD. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics. Due to interpersonal variability, the expression proteins were qualified to satisfy the condition of at least two non-null intensities in replicates of each subgroup.

This resulted in unique proteins that showed high reproducibility between snakebite patients and the healthy control group. The distinct reduction in the number of shared proteins may result from biased estimates in the clinic in identifying similar snakes [ 31 Wuster W, Allum CS, Bjargardottir IB, Bailey KL, Dawson KJ, Guenioui J, et al.

Do aposematism and Batesian mimicry require bright colours? A test, using European viper markings. Proc Biol Sci. However, the wind-fire toxin patients that were bitten by vipers and cobras are distinguished from the fire toxin patients bitten by Agkistrodon acutus and Trimeresurus stejnegeri in TCM.

Based on serum protein expression profiles, we observed a significant distinction in PCA and hierarchical clustering between the wind-fire toxin and fire toxin groups Figure 1B and 1C.

We observed two obvious clusters of significantly upregulated proteins, presented in Figure 1C. Therefore, exploring differences in the serum protein expression profile is effective to distinguish snakebites, as well as for biomarker and antivenom discovery.

Discovering the pathways the identified serum proteins are associated with offers an opportunity for biomarker discovery. DAPs were associated with the hydrogen peroxide catabolic process, carbon-oxygen lyase activity, and heme binding.

Previous studies have demonstrated that venom-induced toxicity elevates reactive oxygen species ROS and hydrogen peroxide levels, implying potential cytotoxicity of venom [ 11 Santhosh MS, Sundaram MS, Sunitha K, Kemparaju K, Girish KS.

Viper venom-induced oxidative stress and activation of inflammatory cytokines: a therapeutic approach for overlooked issues of snakebite management. Inflamm Res. The compound hydrogen peroxide is an important component of ROS, which regulates many cellular functions in limited concentrations, but can also cause damage of cellular organelles, DNA, and proteins when present in excessive concentrations, an effect known as oxidative stress [ 33 Marnett LJ.

Oxyradicals and DNA damage. The interaction network of proteins and drug compounds showed that hydrogen peroxide was highly associated with many DAPs Figure 5. These interacting DAPs were grouped into four clusters, including lipid metabolism and transport, IGF-mediated growth, oxygen transport, and innate immunity.

The venom-induced toxicity activates various oxidases and respiratory burst due to inflammation [ 34 Sampaio SC, Sousa-e-Silva MC, Borelli P, Curi R, Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J Leukoc Biol. Phospholipases A2 PLA2s are abundant components of venom in many snake species, and have the effect of blocking neuromuscular transmission and inducing acute muscle damage [ 35 Gutierrez JM, Lomonte B.

Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins. However, the physiological roles of PLA2s remain unknown. We discovered that a large cluster in the protein interaction network is concentrated in the innate ubiquitin-proteasome.

Protein degradation may potentially be the cellular targets of PLA2s. The molecular composition of venom and serum from snakebite patients may be the most direct and credible way to evaluate the molecular mechanisms underlying the venom-induced toxicity process. Comparison of DAPs in snakebites from different snake species identifies potential biomarkers and provides theoretical support for TCM on the molecular level.

A few proteins participating in the networks were upregulated in the serum of the fire toxin group as compared to the wind-fire toxin group, such as TXN Thioredoxin , CETP Cholesteryl ester transfer protein , IGFBP7 Insulin-like growth factor binding protein 7 , MPO Myeloperoxidase , and SLC4A1 Solute carrier family 4.

Two proteins, FABP6 Fatty acid binding protein 6 and B3GNT1 Beta-1,3-N-acetylglucosaminyltransferase 1 , were only upregulated in the D subgroup Agkistrodon acutus , while four proteins, HSPA8 Heat shock 70kDa protein 8 , CKM Creatine kinase , SEMA4 semaphorin 4B , and SAA1 serum amyloid A1 were only unexpressed in the E subgroup Trimeresurus stejnegeri.

These potential protein biomarkers well illustrated in toxin classification of TCM theory, and provided more biomarkers for identification of snakebite by different snake species. Importantly, the combined DAPs from four snake species suggested that they were mainly involved in the interaction network of proteins and hydrogen peroxide.

Envenomation has been shown to induce redox status imbalance in a few snakes [ 36 Sachetto ATA, Rosa JG, Santoro ML. Rutin quercetinrutinoside modulates the hemostatic disturbances and redox imbalance induced by Bothrops jararaca snake venom in mice. Zengin S, Al B, Yarbil P, Taysi S, Bilinc H, Yildirim C, et al.

J Emerg Med. Aquilano K, Baldelli S, Ciriolo MR. Glutathione: new roles in redox signaling for an old antioxidant. Front Pharmacol. Thus, the DAPs associated with oxidative stress and antioxidant action could be regarded as prior consideration for experimental validation in the future.

Five proteins TXN, CETP, IGFBP7, MPO, and SLC4A1 were potential biomarkers to distinguish fire toxin and wind-fire toxin in classification of TCM theory, and a few proteins could identify snakebite of different snake species.

These potential protein biomarkers were connected into the interaction network of proteins and hydrogen peroxide, which indicated that the venom-induced toxicity of snakebites was associated with oxidative stress and antioxidant defense.

In the future, these potential biomarkers will need to be screened in a larger cohort of patients for clinical application. Open menu Brazil. Journal of Venomous Animals and Toxins including Tropical Diseases. Submission of manuscripts About the journal Editorial Board Instructions to authors Contact.

Português Español. Open menu. table of contents « previous current next ». Text EN Text English. PDF Download PDF English. Toxins incl. Abstract Background: Snakebites remain a major life-threatening event worldwide.

Methods: Cases of snakebite seen at the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine were grouped as follows: fire toxin - including four cases of bites by Agkistrodon acutus and three bites by Trimeresurus stejnegeri - and wind-fire toxin - four cases of bites by vipers and three bites by cobras.

Results: Principal component analysis and hierarchical clustering of unique proteins exhibited protein expression profiles of wind-fire toxins that are distinct from that of fire toxins.

Conclusions: Our results show that the pathways of snake venom-induced toxicity may form a protein network of antioxidant defense by regulating oxidative stress through interaction with hydrogen peroxide. Keywords Snake; Venom; Proteome; Hydrogen peroxide; Antioxidant defense. Background Venomous snakebites have been a common and critical clinical illness since ancient times [ 1 1.

Materials and Methods Patient identification and eligibility The experimental procedures were approved by the Ethics Committee of the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine n.

References 1. Chippaux JP, Massougbodji A, Habib AG. The WHO strategy for prevention and control of snakebite envenoming: a sub-Saharan Africa plan. Kittigul L, Ratanabanangkoon K. Reverse passive hemagglutination tests for rapid diagnosis of snake envenomation. J Immunoassay. Boekholdt SM, Kuivenhoven JA, Hovingh GK, Jukema JW, Kastelein JJ, van Tol A.

CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr Opin Lipidol. Cagnone GL, Sirard MA. Transcriptomic signature to oxidative stress exposure at the time of embryonic genome activation in bovine blastocysts. Mol Reprod Dev. The serum protein quantifications are available in Additional file 2 Additional file 2.

This work was supported by grants from the Natural Science Foundation , , the Natural Science Foundation of Jiangxi BAB, ACB , the Double First-Class Construction Project of Jiangxi Province JXSYLXK-ZHYI , and Science and Technology Project of the Education Department of Jiangxi Province GJ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

The informed consent forms were obtained from all recruited participants 14 snakebite patients and 15 healthy controls in the surgical department of Traditional Chinese Medicine of the Affiliated Hospital. Supplementary material The following online material is available for this article: Additional file 1.

Additional file 2. Additional file 3. Additional file 4. Additional file 5. Publication Dates Publication in this collection 19 Oct Date of issue History Received 16 Apr Accepted 08 Sept Degang Dong School of Life Sciences, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Jiangxi University of Traditional Chinese Medicine China Nanchang, China School of Life Sciences, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Innovative Chinese Medicine Research Institute, Shanghai University of Chinese Medicine, Shanghai, China. Shanghai University of Chinese Medicine China Shanghai, China Innovative Chinese Medicine Research Institute, Shanghai University of Chinese Medicine, Shanghai, China.

Zhongping Deng Innovative Chinese Medicine Research Institute, Shanghai University of Chinese Medicine, Shanghai, China. Zhangren Yan Southern Snake Bite Control Center, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Jiangxi University of Traditional Chinese Medicine China Nanchang, China Southern Snake Bite Control Center, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China. Wenli Mao Southern Snake Bite Control Center, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

The Centers for Snake venom detoxification methods Control and Glycemic load and portion sizes CDC indicates that Snake venom detoxification methods detoxificatiin bite somewhere between 7, and 8, people in detoxificatiion United States detoxificayion year, and about five die. In the U. Rattlesnake: The largest venomous snake in the U. There are 29 species of the rattlesnake, found far and wide across the country. From grassy meadows in the Northeast to swamps in the Southeast — even in the mountains, as they can thrive at up to 11, feet in elevation. However, they are most prevalent in the Southwestern part of the U. Vehom poisons Immune-boosting foods venoms are comprised of different classes Pear-shaped body molecules Snake venom detoxification methods wide-ranging pharmacological activities. This review Brain agility for sports skills to provide an in-depth detoxicication of toxin-based compounds detoxifivation terrestrial and detlxification organisms used kethods diagnostic tools, experimental molecules to Snake venom detoxification methods postulated methofs targets, detoxificatio libraries, prototypes for metjods design of Snake venom detoxification methods, cosmeceuticals, and therapeutic agents. However, making these molecules applicable requires extensive preclinical trials, with some applications also demanding clinical trials, in order to validate their molecular target, mechanism of action, effective dose, potential adverse effects, as well as other fundamental parameters. Here we go through the pitfalls for a toxin-based potential therapeutic drug to become eligible for clinical trials and marketing. The manuscript also presents an overview of the current picture for several molecules from different animal venoms and poisons such as those from amphibians, cone snails, hymenopterans, scorpions, sea anemones, snakes, spiders, tetraodontiformes, bats, and shrews that have been used in clinical trials.